Charles, Susan (Sue) (Instinctif 201611 Manaing Partner Life Sciences before College Group + Northbank + HCC De Facto) |
Public Relations Manager / Investor Relations Manager |
Instinctif Partners (Group) |
United Kingdom (GB) |
Charlon, Vincent (Anergis 201103 CEO) |
Chief Executive Officer (CEO) |
Anergis S.A. |
Switzerland |
Charpentier, Emmanuelle (Helmholtz 201412 Professor at HZI) |
Professor |
Max Planck Society for the Advancement of Science |
Germany |
Chasseloup de Chatillon, Jean-Baptiste (Sanofi 201810– CFO joined 9/18 before PSA Group) |
Chief Financial Officer (CFO) |
Sanofi (Group) [since May 2011] |
France |
Chatterjee, Amit (Sartorius 200910 Managing Director Sartorius India) |
Managing Director |
Sartorius (Group) |
India |
Chatziathanasiou, Mathäos (MZ-Analysentechnik 201402 Managing Director) |
Managing Director |
MZ-Analysentechnik GmbH |
Germany |
Chaud, Bernard (Global Bioenergies 201702 Head of Industrial Strategy) |
Business Development Manager / Strategy Manager |
Global Bioenergies (Group) |
France |
Cheek, Julia (EverlyWell 201907 CEO + Founder) |
Chief Executive Officer (CEO) |
EverlyWell Inc. |
United States (USA) |
Chemnitz, Jan (Provirex 201911– Managing Director) |
Managing Director |
Provirex Genome Editing Therapies GmbH |
Germany |
Chen, Benjamin (Immune Targeting Systems Ltd 201501 CEO) |
Chief Executive Officer (CEO) |
Altimmune (Group) |
United Kingdom (GB) |
Chen, Elbert (Cytena 201907 CFO of Cytena Bioprocess Solutions Co Ltd) |
Chief Financial Officer (CFO) |
Cellink (Group) |
Taiwan |
Chen, Henry (Delos Capital 2014– Managing Partner + Co-Founder) |
n. a. |
Delos Capital (Delos Advisors Ltd.) |
China |
Chen, Irene (DKSH 201804 Group Communications Manager of Business Unit Technology) |
Public Relations Manager / Investor Relations Manager |
DKSH (Group) |
Switzerland |
Chen, Shuqi (IQuum 201404 CEO + Co-founder) |
Chief Executive Officer (CEO) |
Roche (Group) |
United States (USA) |
Chen, Zhisheng (Chris) (WuXi Pharmatech 201812 CEO of WuXi Biologics) |
Chief Executive Officer (CEO) |
WuXi PharmaTech (Group) |
China |
Cheng, Jing (CapitalBio 200504 CEO + CTO) |
Chief Executive Officer (CEO) |
CapitalBio (Group) |
China |
Cherkasov, Dmitry (GenoVoxx 200502) |
n. a. |
GenoVoxx GmbH |
Germany |
Cheruvu, Pavan (Roivant 201806 CEO of Axovant Sciences) |
Chief Executive Officer (CEO) |
Sio Gene Therapies Inc. (Nasdaq: SIOX) |
United States (USA) |
Chhaya, Mohit (BellaSeno 202007 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
BellaSeno GmbH |
Germany |
Chiam, Maria (Go To Market Consulting Inc 201309 Founder) |
Company Founder |
Go To Market Consulting Inc. |
United States (USA) |
Chicca, Andrea (Synendos Therapeutics 202011 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Synendos Therapeutics AG |
Switzerland |
Chickosky, John (Natrix Separations 201708 CEO) |
Chief Executive Officer (CEO) |
Merck (DE) (Group) |
Canada |
Chiesi, Antonio (HansaBioMed Life Sciences OÜ 201705 Managing Director + Exosomics Siena SpA 201705 CEO) |
Managing Director |
Lonza (Group) |
Estonia |
Chiesi, Paolo (Chiesi 201309 VP + RnD Director) |
Research & Development Manager |
Chiesi (Group) |
Italy |
Chiswell, David (Kymab 201604–201904 CEO before interim CEO since early 2015 before Nabriva + Albireo + CAT + Amersham) |
Chief Executive Officer (CEO) |
Sanofi (Group) [since May 2011] |
United Kingdom (GB) |
Chiva, Cristina (Centre for Genomic Regulation CRG 201201 Acting Manager of CRG/UPF Proteomics Unit) |
Head Mass Spectrometry / NMR Laboratory (university / research institute) |
Centre for Genomic Regulation (CRG) (Spain) |
Spain (España) |
Cho, Jeong-Woo (SK Group 201902 CEO of SK Biopharmaceuticals) |
Chief Executive Officer (CEO) |
SK Group (Group) |
|
Cho, Sung Hee (FCB-Pharmicell 201010– Managing Director of Pharmicell Europe GmbH) |
Managing Director |
RNL Bio (Group) |
Germany |
Chornet, Nicolas (Moderna 202009 SVP International Manufacturing Europe) |
Production Manager |
Moderna (Group) |
Switzerland |
Choulika, André (Cellectis 200701 CEO + co-founder) |
Chief Executive Officer (CEO) |
Cellectis (Group) |
France |
Chowrira, Bharatt (PureTech Healtch 201703– Chief of Business + Strategy before Synlogic + Auspex + Addex + Nektar) |
Business Development Manager / Strategy Manager |
PureTech Health (Group) |
United Kingdom (GB) |
Chrintz, Ole (Lundbeck 201304 SVP International Markets + Europe) |
President/Director/Head Business Group/Unit/Division |
Lundbeck (Group) |
Denmark |
Chrisman, Anna (Informa 201511 Managing Director at EBD Group) |
Managing Director |
Informa plc (Group) |
United States (USA) |
Christ, Arnd (Immatics 202010– CFO before InflaRx + Proteros + MediGene + NovImmune + Probiodrug + Hoechst) |
Chief Financial Officer (CFO) |
Immatics (Group) |
Netherlands |
Christ, Joachim (Merck (DE) 201704– Chief Procurement Officer before Head of Group Controlling) |
management (personnel) |
Merck (DE) (Group) |
Germany |
Christel, Luca Pascal (Apoly GmbH 201601 Managing Director) |
Managing Director |
Apoly GmbH |
Germany |
Christély, Thomas (MYR GmbH 202008 Managing Director before Atugen AG 200702 CEO) |
Managing Director |
Gilead Sciences (Group) |
Germany |
Christgau, Stephan (Eir Ventures 202007– before Novo Seeds + Osteologix) |
Investment Manager |
Eir Ventures |
Sweden |
Christian, Monty (Bayer 200905 Director Global Cotton Marketing at Bayer CropScience) |
Sales Manager / Marketing Manager |
Bayer (Group) |
Germany |
Christiansen, Claus (CCBR + Nordic Bioscience Founder + Chairman) |
Company Founder |
CCBR (Group) |
Denmark |
Christine, Rainer (Science to Market Venture Capital 201108– Managing Director before amaxa 200407 CEO + co-founder) |
Managing Director |
Science to Market Venture Capital (Group) |
Germany |
Chun, Jong-Yoon (Seegene 200705 CEO + founder) |
Chief Executive Officer (CEO) |
Seegene (Group) |
Korea, Republic of |
Chung, Ping Chow (Genedata 201812– Managing Director of Genedata Pte Ltd) |
Managing Director |
Genedata Pte. Ltd. |
Singapore |
Church, George (Harvard Univ Prof) |
Professor |
Harvard University |
United States (USA) |
Cicek, Aslan (Selektis GmbH 201502 Managing Director) |
Managing Director |
Selektis GmbH |
Germany |
Cichocka, Danuta (Resistell 201912 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Resistell AG |
Switzerland |
Ciftlik, Ata Tuna (Lunaphore Technologies 201404– CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Lunaphore Technologies S.A. |
Switzerland |
Ciller, Carlos (RetinAI Medical 202012 CEO) |
Chief Executive Officer (CEO) |
RetinAI Medical AG |
Switzerland |
Cimpan, Gabriela (ACD/Labs 201605 Director of Sales Europe) |
Sales Manager / Marketing Manager |
Advanced Chemistry Development (ACD/Labs) (Group) |
United Kingdom (GB) |
Ciulli, Alessio (Univ Dundee 201607 Associate Professor of Chemical + Structural Biology) |
Professor |
University of Dundee |
United Kingdom (GB) |
Claessen, Rolf (Freischem Patentanwälte 201005–) |
Patent Attorney |
Freischem & Partner Patentanwälte mbB |
Germany |
Clark, Chad (Precision for Medicine 201710 COO) |
Chief Operating Officer (COO) |
Precision Medicine Group (Group) |
United States (USA) |
Clark, Ian T. (Kite Pharma 201701– Non-executive Board Director before Roche/Genentech + Novartis + Sanofi + Ivax) |
Board member, non-executive |
Gilead Sciences (Group) |
United States (USA) |
Clark, Martin (MorphoSys 201205– head Central Purchasing + Logistics before Sandoz Biopharmaceuticals + Basilea) |
Commercial Manager_oo |
MorphoSys (Group) |
Germany |
Clark, Mary (Optimum Strategic Communications 201710 before Hume Brophy + M:Communications + Capital MSL) |
Public Relations Manager / Investor Relations Manager |
Optimum Strategic Communications |
United Kingdom (GB) |
Clark, Pamela (Pam) (Bruker Corp 201905 Investor Relations) |
Public Relations Manager / Investor Relations Manager |
Bruker (Group) |
United States (USA) |
Clark, Tim (Univ Erlangen-Nuremberg 200411 Professor) |
Professor |
University of Erlangen-Nuremberg (Friedrich Alexander University, FAU) |
Germany |
Clarkson, John (Atlas Genetics 201107 CEO) |
Chief Executive Officer (CEO) |
Atlas Genetics Ltd. |
United Kingdom (GB) |
Classon, Rolf |
n. a. |
Bayer (Group) |
Germany |
Clausnitzer, Nils (VWR International 201705 SVP + President EMA-APAC Lab + Distribution Services) |
President/Director/Head Business Group/Unit/Division |
Avantor (Group) |
United States (USA) |
Claussen, Carsten (Fraunhofer IME ScreeningPort before European ScreeningPort + Evotec Technologies) |
Managing Director |
Fraunhofer (Group) |
Germany |
Claussen, Ralf (Eppendorf 201705 Head of Advertising + Communications) |
Public Relations Manager / Investor Relations Manager |
Eppendorf (Group) |
Germany |
Clayman, Michael (Flexion Therapeutics 201712 CEO) |
Chief Executive Officer (CEO) |
Flexion Therapeutics Inc. (Nasdaq: FLXN) |
United States (USA) |
Cleary, Alan (London Premier College 201203) |
n. a. |
London Premier College |
United Kingdom (GB) |
Cleiftie, Jean-Sébastien (Erytech 201610– CBO before Sanofi + Innoven Partners + Aventis) |
Chief Business Officer (CBO) |
Erytech (Group) |
France |
Clein, Mark P. (Precision for Medicine 2012– CEO + Co-Founder before United BioSource Corp) |
Chief Executive Officer (CEO) |
Precision Medicine Group (Group) |
United States (USA) |
Clemens, Ralf (CureVac 201603 SAB + Supervisory Board Member before GSK Biologicals + Novartis) |
scientific advisory board (SAB) |
|
|
Clement, Tom (Qiagen 200901– VP Regulatory and Clinical Affairs before Roche + bioMérieux + Amersham) |
Regulatory Affairs Manager |
Qiagen (Group) |
Netherlands |
Clement, Wolfgang (BMWA 200501) |
n. a. |
Germany (govt) |
Germany |
Clifford, Matt (Entrepreneur First 2020 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Entrepreneur First (EF) |
United Kingdom (GB) |
Cline, Timothy (Bruker Corp 201804 VP Global Sales at Bruker AXS) |
Sales Manager / Marketing Manager |
Bruker (Group) |
Germany |
Cloppenburg, Conny (4 Animals AlsterScience GmbH 201409 Managing Director) |
Managing Director |
4 Animals AlsterScience GmbH |
Germany |
Close, Sven (EnjoyVenture 201208 Senior Investment Manager) |
Investment Manager |
EnjoyVenture (Group) |
Germany |
Clouston, Myles (MorphoSys 202012 Senior Director Investor Relations) |
Public Relations Manager / Investor Relations Manager |
MorphoSys (Group) |
Germany |
Clozel, Jean-Paul (Actelion 200607 CEO) |
Chief Executive Officer (CEO) |
Johnson & Johnson (JnJ) (Group) |
Switzerland |
Clozel, Martine (Actelion 201108 CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Johnson & Johnson (JnJ) (Group) |
Switzerland |
Cmiljanovic, Vladimir (Piqur Therapeutics 201507 CEO + Co-Founder) |
Chief Executive Officer (CEO) |
Piqur Therapeutics AG |
Switzerland |
Cobb, Samantha (AdAlta Pty Ltd 201412 CEO) |
Chief Executive Officer (CEO) |
AdAlta Pty Ltd. |
Australia |
Cocero, Nanette (Pfizer 202004 Global President of Pfizer Vaccines) |
President/Director/Head Business Group/Unit/Division |
Pfizer (Group) |
United States (USA) |
Cohen, Jon R. (Quest Diagnostics 201103 SVP + CMO) |
Chief Medical Officer (CMO) |
Quest Diagnostics (Group) |
United States (USA) |
Cohen, Katherine (Hookipa Biotech 2011–201606 CEO + Founder before Intercell) |
Managing Director |
Hookipa (Group) |
Austria |
Cohen-Dayag, Anat (Compugen 201112 CEO) |
Chief Executive Officer (CEO) |
Compugen (Group) |
Israel |
Cohen-Tanugi, Ivan (Eyevensys 201303– CEO before Teva US + Roche Pharma + Amgen) |
Chief Executive Officer (CEO) |
Eyevensys (Group) |
France |
Colarusso, Thomas (Definiens 201106 VP Sales + Operations at Definiens Inc.) |
Sales Manager / Marketing Manager |
AstraZeneca (Group) |
United States (USA) |
Cole, Alun (Markes International 200908 Director of ALMSCO International division) |
President/Director/Head Business Group/Unit/Division |
Schauenburg (Group) |
United Kingdom (GB) |
Coleman, Michael (InGeneron 201005 Managing Director) |
n. a. |
|
|
Coles, Anthony (Tony) (Cerevel 201909– CEO before Yumanity Therapeutics + Onyx + NPS + Vertex + BMS + Merck US) |
Chief Executive Officer (CEO) |
Cerevel Therapeutics LLC |
United States (USA) |
Colinge, Jacques (Austrian Academi of Sciences 201202 Ce-M-M-Research Center for Molecular Medicine) |
Researcher (university / research institute) |
Austrian Academy of Sciences (ÖAW) |
Austria |
Collasius, Michael (Qiagen 200705 VP Automated Systems) |
n. a. |
Qiagen (Group) |
Germany |
Collins, John |
n. a. |
Cosmix (Group) |
Germany |
Collins, Peter (4titude Ltd 201710 Co-Founder) |
Company Founder |
Brooks Automation (Group) |
United Kingdom (GB) |
Colloca, Stefano (Nouscom 201806 CTO) |
Chief Technology/Technical Officer (CTO) |
Nouscom (Group) |
Switzerland |
Colpan, Metin (Qiagen CEO + co-founder) |
Chief Executive Officer (CEO) |
Qiagen (Group) |
Germany |
Comb, Michael J. (Cell Signaling Technology 200907 CEO + Founder) |
Chief Executive Officer (CEO) |
Cell Signaling Technology (CST) (Group) |
United States (USA) |
Combal, Jean-Philippe (Vivet Therapeutics 201705 CEO + Co-Founder before Gensight Biologics + Sanofi) |
Chief Executive Officer (CEO) |
Vívet Therapeutics (Group) |
France |
Combé, Nicolas (Nanohale 201102 CFO) |
Chief Financial Officer (CFO) |
Formycon (Group) |
Germany |
Compton, Carolyn (Arizon State Univ + Mayo Clinic 201502 Professor + former Director of NCI OBBR) |
Professor |
Arizona State University (ASU) |
United States (USA) |
Conca, James (RJ Lee Group 201306 Director Analytical Services) |
President/Director/Head Business Group/Unit/Division |
RJ Lee Group Inc. |
United States (USA) |
Condie, Jamie (BD Diagnostics 200807 VP + General Manger) |
n. a. |
Becton, Dickinson (Group) |
United States (USA) |
Condon, Liam (Bayer 201212– CEO of Bayer CropScience before Managing Director Bayer Vital before Schering) |
Chief Executive Officer (CEO) |
Bayer (Group) |
Germany |